ScreenerHero

NMTC NeuroOne Medical Technologies Corporation

NAS · US · Healthcare · Medical Devices · nmtc1.com
1.110USD-1.77%Mkt Cap: 10.11M $P/E: —

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company …

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$171.97BUSDP/E 31.8
MDT
Medtronic plc
$109.38BUSDP/E 21.0
SYK
Stryker Corporation
$105.64BUSDP/E 28.5
BSX
Boston Scientific Corporation
$60.26BUSDP/E 16.8
EW
Edwards Lifesciences Corporation
$49.39BUSDP/E 51.1
SHL
Siemens Healthineers AG
$46.91BUSDP/E 19.6
DXCM
DexCom, Inc.
$31.81BUSDP/E 33.5
GEHC
GE HealthCare Technologies Inc.
$29.42BUSDP/E 14.9
PHIA
Koninklijke Philips N.V.
$22.87BUSDP/E 18.7
PHG
Koninklijke Philips N.V.
$23.55BUSDP/E 18.0
STE
STERIS plc
$20.44BUSDP/E 25.6
SOON
Sonova Holding AG
$17.11BUSDP/E 28.0
ZBH
Zimmer Biomet Holdings, Inc.
$16.88BUSDP/E 21.5
PEN
Penumbra, Inc.
$12.46BUSDP/E 77.7
SNN
Smith & Nephew plc
$11.25BUSDP/E 18.3
DEMANT
Demant A/S
$9.87BUSDP/E 28.0
GKOS
Glaukos Corporation
$10.16BUSD
TXG
10x Genomics, Inc.
$9.92BUSD
GMED
Globus Medical, Inc.
$9.90BUSDP/E 18.9
BIO
Bio-Rad Laboratories, Inc.
$9.85BUSDP/E 46.6

Key Statistics

Company
Market Cap10.11M USD
Enterprise Value8.42M USD
Revenue (TTM)12.47M USD
Gross Profit5.14M USD
Net Income (TTM)-3.61M USD
Revenue/Share1.47 USD
Last Price1.110 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees18
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.04
PEG—
EV/EBITDA-1.10
EV/Revenue0.68
P/S0.83
P/B2.61
EPS (TTM)-0.99
EPS (Forward)-0.28
52W Range
0.96152% of range6.960
52W High6.960 USD
52W Low0.9615 USD
Profitability
Gross Margin56.51%
Oper. Margin-122.87%
EBITDA Margin-61.46%
Profit Margin-39.63%
ROE-50.98%
ROA-33.43%
Growth
Revenue Growth16.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.84M USD
CapEx (TTM)81.74K USD
FCF Margin-36.62%
FCF Yield-45.18%
Net Debt-1.87M USD
Net Debt/EBITDA0.24
Balance Sheet
Debt/Equity0.04
Current Ratio2.84
Quick Ratio1.54
Book Value/Sh0.43 USD
Cash/Share0.23 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateApr 16, 2026
Analyst Consensus
Rating—
Target (Mean)7.267 USD
Upside (mean)+554.7%
Target Range5.000 USD – 8.800 USD
5.000+554.7% to mean8.800
# Analysts3
Ownership
Shares Out.9.11M
Float6.26M
Insiders25.44%
Institutions22.45%
Short Interest
Short Ratio0.1d
Short % Float0.86%
Short % Out.0.83%
Shares Short75.78K
Short (prev mo.)82.08K
Technical
SMA 501.610 (-31.1%)
SMA 2003.569 (-68.9%)
Beta0.76
S&P 52W Chg16.45%
Avg Vol (30d)153.93K
Avg Vol (10d)231.65K
Technical Indicators
RSI (14)33.0
MACD-0.1874
MACD Signal-0.1883
MACD Hist.+0.0009
BB Upper1.743 USD
BB Middle1.320 USD
BB Lower0.8967 USD
BB Width64.13%
ATR (14)0.1421 USD
Vol Ratio (20d)0.66x